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Aim: This study aims to evaluate adherence to a clinical guideline for screening and prevention of neonatal hypoglycaemia on the post-natal
wards.
Methods: Retrospective chart review of 581 healthy term neonates born at a tertiary maternity hospital. Indications for hypoglycaemia
screening included small for gestational age (SGA), infants of diabetic mothers (IDM; gestational, Type 1 or 2), symptomatic hypoglycaemia,
macrosomia and wasted (undernourished) appearance. Outcomes were protocol entry and adherence with hypoglycaemia prevention strate-
gies including early and frequent feeding and timely blood glucose measurement.
Results: Of 115 neonates screened for hypoglycaemia, 67 were IDM, 19 were SGA (including two both IDM and SGA), and two were
macrosomic. One IDM and one SGA were not screened. Twenty-two neonates were screened for a reason not identiﬁable from the medical
record, and 13 neonates were SGA by a deﬁnition different to the guideline deﬁnition, including ﬁve whowere also IDM. Guideline adherence was
variable. Few neonates (41 of 106, 39%) were fed in the ﬁrst post-natal hour, and blood glucose measurement occurred later than recommended
for 41 of 106 (39%) of neonates.
Conclusions: Most IDM and SGA neonates were screened. While guideline adherence overall was comparable with other studies, neonates
were fed late. We recommend staff education about beneﬁts of early (within the ﬁrst hour) frequent breastfeeding for neonates at risk.
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What is already known on this topic
1 Neonatal hypoglycaemia though rare can have severe outcomes
including death and neurological deﬁcits.
2 Most hospitals in Australia have clinical guidelines to screen for
and prevent the condition.
3 The effectiveness of clinical practice guidelines requires
assessment.
What this paper adds
1 This is the ﬁrst published study of adherence to neonatal
hypoglycaemia guidelines in Australia.
2 Timely initiation of breastfeeding within the ﬁrst hour after birth
and initiation of blood glucose measurement were suboptimal
and are important indicators for re-evaluation.
3 Identiﬁcation of small for gestational age and infants of diabetic
mothers at risk of hypoglycaemia was very good.*
Neonatal hypoglycaemia is associated with poor neuro-
developmental outcomes, brain damage and death.1–3 Most Aus-
tralian hospitals with a neonatal unit report using clinical
guidelines to identify and treat neonatal hypoglycaemia.4 Evi-
dence about the consequences of neonatal hypoglycaemia,
optimal management and impact of treatment on outcomes is
limited,5–7 therefore neonatal hypoglycaemia guidelines are
based largely on expert opinion and ‘operational thresholds’.8
The effectiveness of any clinical practice guidelines requires
assessment. Assessment for hypoglycaemia should include
whether the guidelines are adhered to and increase detection
and reduce severity of hypoglycaemic episodes in those
screened. However, there is little published research on adher-
ence to such guidelines.9–11
The aim of this study was to examine in a sub-population of
healthy term neonates adherence to a clinical guideline for
neonatal hypoglycaemia screening in a large, tertiary maternity
hospital in Sydney, Australia. The specific objectives were
twofold: (i) to determine the proportion of neonates considered
at risk of hypoglycaemia that were screened for hypoglycaemia;
and (ii) to determine adherence to the clinical practice guideline.
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Materials and Methods
Guideline entry – screening
The study population included term healthy neonates born and
managed on the post-natal ward at Royal Prince Alfred Hospital
(RPAH), Sydney, Australia, between September and October
2010. The number of these neonates who had blood glucose
screening was determined by chart review to estimate the pro-
portion of neonates who received hypoglycaemia screening out
of those who had an indication for screening. According to the
protocol, indications for hypoglycaemia screening included (i)
an infant of a diabetic mother (IDM; gestational, Type 1 or Type
2), with gestational diabetes mellitus diagnosed according to the
Australasian Diabetes in Pregnancy Society criteria12 and deter-
mined by maternal and laboratory record review; (ii) small for
gestational age (SGA), defined as birthweight <2500 g for 37–38
months, <2600 g for 39 months and <2800 g for 40+ weeks
gestation; (iii) symptomatic hypoglycaemia defined by signs
including poor feeding and jitteriness; (iv) wasted appearance;
and (v) macrosomic appearance, with increased subcutaneous
fat, plethora and a relatively small head (Appendix S1).
Guideline adherence
A checklist of seven criteria was developed from the guideline
(Appendix S1), and the proportion of neonates whose man-
agement complied with each criterion was determined by
reviewing the feeding charts of those neonates screened for
hypoglycaemia who remained on the post-natal ward. A ‘feed’
was defined as a code 5 or 6 out of 6 breastfeed indicating
good nutritive sucking or EBM or formula as recorded on the
chart reasoning that only nutritive feeds alter blood glucose.
Adherence to the following criteria was calculated: (i) first
feed within first hour after birth; (ii) fed at least five times in
the first 24 h; (iii) second feed in the first 6 h; (iv) blood
glucose measured after the second feed; (v) glucose measured
within 7 h of birth; (vi) at least three blood glucose levels
measured; and (vii) had glucose monitoring for at least 12 h
after birth. We were also able to measure time discrepancies to
the time dependent criteria. We examined the relationship
between mode of delivery and adherence.
Hypoglycaemia incidence (according to positive
screening test)
All blood glucose measurements on the feeding charts
were recorded to document the incidence of hypoglycaemia,
which was defined as blood glucose level 2.0 mM in the first
24 h and 2.5 mM afterwards for full-term asymptomatic
neonates. Capillary blood was obtained by heel prick and
glucose levels measured using the Accu-Check Advantage
(Roche Diagnostics, Castle Hill, Australia) glucometre and test
strips. These glucometres were subject to monthly quality
assurance review.
Statistical analysis
We used t-tests to compare continuous demographic variables.
Associations between discrete variables were investigated using
the Fisher’s exact c2 test and the rate ratio (RR) estimated.
P-values less than 0.05 were considered statistically significant.
The 95% confidence intervals were estimated for the percentage
adherence to each guideline criterion. All analyses were con-
ducted in Stata 11.2 (Stata Corporation, College Station, TX,
USA).
The study was approved by the Human Research Ethics
Committees of RPAH (HREC/09/RPAH645, SSA/09/RPAH646)
and the University of Sydney (Ref. no. 12732).13 Informed
parental written consent was obtained, and participation was
voluntary.
Results
Guideline entry
Of the 581 full-term neonates, 115 (20%) had at least one
glucose level measured. Neonates on the guideline were
younger, smaller, more commonly born to primiparous women,
more likely to have an Asian mother and less likely to have had
a normal vaginal delivery (NVD) (Table 1). Most neonates at risk
of hypoglycaemia according to the guideline were screened,
with only one of 68 IDM and one of 19 SGA neonates missed
(Table 2); two neonates were both IDM and SGA. The missed
SGA infant weighed only 5 g less than the 2800 g cut-off. There
were no cases of clinically detected hypoglycaemia.
Of the neonates on the hypoglycaemia guideline, 13 (includ-
ing five that were also IDM) were SGA defined by <10th per-
centile weight for gestational age but not SGA according to the
guideline definition, two were macrosomic and we could not
determine the entry criteria for the remaining 22 (19%). The
total number of neonates who were identified as wasted or
macrosomic by clinicians was not known as this was not
recorded.
Guideline adherence
Nine neonates screened for hypoglycaemia were excluded
from the guideline audit as they were subsequently admitted
to the neonatal intensive care unit where different guideline
actions are required. None of these were admitted for
hypoglycaemia. Feeding charts of 106 neonates were
reviewed. All seven adherence criteria were followed for 35
neonates (33%), six of seven criteria for 25 neonates (24%),
five criteria for 23 neonates (22%), four criteria for 15
neonates (14%), three criteria for six neonates (6%) and two
criteria for two neonates (2%). No neonates had one or fewer
of the seven criteria followed. Over the seven criteria (Fig. 1),
the median percentage adherence was 73%. A sensitivity
analysis excluding neonates with an unknown indication for
screening (n = 80 IDM and/or SGA neonates) showed similar
results (data not shown).
The most common adherence problem was feeding in the first
hour; of the 106 babies, only 41 (39%, 95% confidence interval
(CI) 29, 49), received a nutritive feed in the first hour after birth
of the 80 babies with a known indication for screening this
number was 34 (43%, 95% CI 33, 53) (Fig. 1). The median time
between birth and the first nutritive feed was 1 h and 26 min for
the 106 (Fig. 2) and 1 h and 15 min for the 80 neonates. As
good nutritive sucking in the perinatal period is not always
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achieved, we conducted a sensitivity analysis of any breastfeed-
ing and found very similar results; 47 of 106 (44%; 95% con-
fidence interval 34% to 54%) neonates were fed in the first
hour with a median duration of 1 h and 10 min between birth
and the first feed. Neonates delivered by Caesarean section
compared with NVD were more likely to be fed late (RR 1.68,
95% CI 1.18, 2.39, P = 0.004; n = 106).13
The second most common problem was timing of the first
blood glucose measurement. The median time between birth
and the first blood glucose measurement was 6 h and 34 min
and 65 of 106 neonates (61%, 95% CI 51, 71) had glucose
measured within 7 h from birth. When babies with an
unknown indication for screening were excluded, the median
time was 6 h and 15 min and 53 of 80 neonates (66%; 95% CI
56, 75) had glucose measured within 7 h from birth.
Hypoglycaemia incidence (according to positive
screening test)
There were 341 glucose levels recorded for 106 neonates, an
average of 3.2 per neonate. No blood glucose levels were
Table 1 Characteristics of study population and comparison of total population to those screened for hypoglycaemia
Total study population (n = 581) Neonates screened for hypoglycaemia (n = 115)
Mean SD Mean SD P
Gestational age (week) 39.5 1.12 39.2 1.18 <0.001*
Birthweight (g) 3435 465 3186 609 <0.001*
Mother’s mean age 31.5 5.37 31.8 4.72 0.541
5 min Apgar score 8.97 0.597 8.88 0.651 0.0544
n (%) n % P
Sex (male) 301 (52) 58 (51) 0.073
Parity (primipara) 328 (56.5) 79 (68.7) 0.003*
Maternal country of birth 0.001*
Australian, New Zealander or other Paciﬁc 277 (47.7) 42 (36.5)
Asian 193 (33.2) 57 (49.6)
European 77 (13.3) 10 (8.70)
Other 30 (5.16) 6 (5.22)
Unknown 4 (0.69) 0 (0)
Highest level of education 0.214
Tertiary 400 (68.9) 86 (74.8)
Secondary or less 165 (28.4) 28 (24.4)
Unknown 16 (2.75) 1 (0.87)
Hypertension 0.298
Gestational 26 (4.48) 10 (8.70)
Pre-eclampsia 11 (1.89) 2 (1.74)
Chronic pre-existing 3 (0.516) 0 (0)
Mode of delivery 0.008*
Vaginal 318 (54.7) 49 (42.6)
Elective CS 76 (13.1) 19 (16.5)
Emergency CS 91 (15.7) 26 (22.6)
Vacuum or forceps 95 (16.4) 20 (17.4)
Unknown 1 (0.17) 1 (0.87)
*Statistically signiﬁcant difference. SD, standard deviation.
Table 2 Guideline entry by indication for hypoglycaemia screening
Total Guideline
applied
(%)
IDM 68 67 (99)
GDM 66 65 (98)
Type 1 DM 1 1 (100)
Type 2 DM 1 1 (100)
Macrosomic Unknown 2
SGA deﬁned by protocol 19 18 (95)
SGA deﬁned by <10th percentile 45 31† (69)
Other on protocol (wasted, unwell) Unknown 22
Groups are not mutually exclusive. †Including 13 not included in the ‘SGA
per protocol’ group, ﬁve of whom were also infants of diabetic mothers;
note that not all of the 45 SGA infants needed to be screened.
DM, diabetes mellitus; GDM, gestational diabetes mellitus; IDM, infant of
a diabetic mother; macrosomic, increased subcutaneous fat, plethora
and relatively small head; SGA, small for gestational age.
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2.0 mmol/L; 14 (4%) glucose levels from nine (8%) neonates
were 2.5 mmol/L in the first 24 h and none after this. These
screening test glucose levels were not persistently low and so
formal laboratory blood glucose testing was not indicated
according to the guideline.
Discussion
Our audit of hypoglycaemia screening practices on the post-
natal ward found most neonates at risk of hypoglycaemia were
screened. The first feed following birth however occurred later
than recommended as did the initial blood glucose test. No
episodes of clinically detected hypoglycaemia were recorded.
This study provides detailed information on adherence to a
hypoglycaemia guideline for a large tertiary referral hospital.
Only one previous audit of a hypoglycaemia guideline is avail-
able in the literature that examines practice in a Canadian
hospital,11 and there are two published conference abstracts
from the UK.9,10
Based on the indications for screening we were able to accu-
rately identify, 84 of 86 (98%) SGA and/or IDM infants were
correctly screened for hypoglycaemia. It is possible however
that the true screening rate for neonates at risk of hypoglycae-
mia was lower, with wasted, macrosomic and symptomatic
neonates missed. In previous audits, 23 of 397 (6%) and 38 of
208 (18%) neonates at risk of hypoglycaemia were missed.10,11
Fig. 1 Percentage adherence to the seven criteria of the RPAH hypoglycaemia guideline. n = 106.
(a) (b)
Fig. 2 Distribution of time from birth at which speciﬁc guideline actions took place. BGL, blood glucose level. (a) Shows all actions; (b) shows the ﬁrst feed.
According to the guideline, the period between birth and the ﬁrst feed should be <1 h, the period between birth and the second feed should be <6 h, the ﬁrst
glucose measurement should be performed 30 min after the second feed and glucose monitoring should be continued for at least 12 h after birth.14 n = 106.
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Regarding adherence, the guideline was correctly followed for
the majority of neonates, with six or seven out of seven criteria
met for 60 of 106 (57%), a result comparable with a previous
audit that found the hypoglycaemia protocol was followed cor-
rectly for 62% of infants.10 Our results reflect a recent study of
neonatal transport centres, with 73% of the guideline adhered
to compared with 79% of blood glucose measurements being
taken after an intervention to improve adherence.15 Most
neonates however were not fed within the first hour after birth,
particularly babies delivered by Caesarean section. This result
remained following a sensitivity analysis of feeding criteria,
using ‘any feed’ (codes 1, 2, 3, 4, 5, 6 or expressed breast milk
(EBM) or formula) compared with a more stringent nutritive
feed (code 5 or 6 or EBM or formula). Early enteral feeding
particularly with breast milk, which promotes metabolic adap-
tation to life outside the uterus16 and reduces the need for
glucose by supplying alternative energy substrates,17 is recom-
mended by the World Health Organization18 and early feeding
reduces the rate of hypoglycaemia in GDM infants compared
with later feeding.19 A median difference of 26 min is clinically
significant, and our previous work shows that neonates receiv-
ing their first feed within 1 h of birth are less likely to have
feeding morbidity compared with those fed between 1 h and 2 h
after birth or later.13
Late detection of low blood glucose levels delays treatment
and may increase morbidity. As was found in previous audits,9,11
blood glucose testing was delayed. This remained true when
babies with an unknown indication for screening were
excluded. The median delay of 34 min we found was however
better than delays found in the Canadian audit, where ‘2 h
blood glucose levels’ were recorded at an average of 2 h and
44 min for SGA and 3 h and 4 min for LGA infants.11 However,
in our study, the proportion that were tested late, 41 of 106
(39%) was much higher than that in another audit, 23 of 170
(13%).10 There is little evidence on the optimal timing for the
first glucose level; however, current recommendations suggest
screening should begin before the second feed, by 6 h of age.20
There was no hypoglycaemia detected using the screening
blood glucose threshold of 2.0 mmol/L in the first 24 h as at
RPAH; however, 9% of neonates experienced screening glucose
levels 2.5 mmol/L that would be consistent with hypoglycae-
mia at other Australian centres.4 Though definitions of hypogly-
caemia are variable,21 these rates are lower than previous studies,
in which hypoglycaemia incidence as high as 51% for infants at
risk.11,22–24 Our low rates may be explained by several factors
including: (i) glucose measurement occurring after feeds, when
glucose levels are highest, rather than before feeds as is recom-
mended25; (ii) beginning screening at around 6 h of age thus
missing the neonatal blood glucose nadir16; (iii) good prevention
strategies with early and frequent breastfeeding; or (iv) overes-
timation of glucose levels by the glucometre, which has a
sensitivity of only 64.3% and specificity of 75% for levels <
2.0 mmol/L compared with laboratory analysis.26 It may also be
due to failure to identify and measure blood glucose levels of
neonates at risk of hypoglycaemia such as wasted neonates.
The strengths of this study include a first Australian audit of
hypoglycaemia guidelines and an attempt to include informa-
tion on feeding. In contrast, this study was conducted retrospec-
tively, and the indication for screening was not available in the
medical record for 22 neonates. The total number of macro-
somic, clinically wasted neonates and those showing potential
signs of hypoglycaemia was not known, which may have caused
ascertainment bias in our assessment of screening babies at risk.
This limitation would however not affect assessment of timely
feeding and blood glucose detection for those neonates being
screened. The point-of-care glucometres used may additionally
have provided inaccurate glucose readings,27 which could
either underestimate or overestimate the incidence of hypogly-
caemia but not affect to whom and when glucose screening
was done.
The audit findings have led to changes, including feeding back
information on early feeding to staff, increasing midwife
numbers in recovery to facilitate breastfeeding after Caesarean
section, measuring percentage body fat to identify wasted
neonates,28 auditing blood glucose analysers and including
information from the hypoglycaemia guideline on feeding
charts to remind staff to screen at the point of care. New
research is also emerging that may necessitate updated guide-
lines.7 Once these changes are all established, guideline adher-
ence will need to be re-audited.
This audit of hypoglycaemia screening practices at a large
tertiary maternity hospital found that identification of SGA and
IDM neonates for screening was good; however, that guideline
adherence could be improved. Unfortunately, we do not know
the extent to which nursing and medical staff were educated
and or informed of this guideline when it was implemented,
whether they interpreted it the same way and whether they
believed it made sense in terms of their clinical experience;
however, it is similar to a previous version of the guideline so we
expect their knowledge was good. Previous audits indicate
adherence may be improved by simplifying the seven-page
hypoglycaemia guideline9 and educating staff.15 A multifaceted
strategy including audit and feedback facilitated by local opinion
leaders would also improve guideline adherence.29 Education
should focus on the benefits of early breastfeeding including
provision of alternative energy substrates to glucose for brain
metabolism and fewer feeding problems and the need to check
blood glucose at the second feed.
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